scispace - formally typeset
D

Daniel F. Legler

Researcher at University of Konstanz

Publications -  99
Citations -  8518

Daniel F. Legler is an academic researcher from University of Konstanz. The author has contributed to research in topics: Chemokine receptor & Chemokine. The author has an hindex of 37, co-authored 90 publications receiving 7738 citations. Previous affiliations of Daniel F. Legler include University of British Columbia & Ludwig Institute for Cancer Research.

Papers
More filters
Journal ArticleDOI

The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1

TL;DR: The identification of a human chemokine of the CXC type, stromal cell-derived factor 1 (SDF-1), as the natural ligand for LESTR/fusin, and the term CXCR-4 is proposed for this receptor, in keeping with the new Chemokine-receptor nomenclature.
Journal ArticleDOI

B Cell–attracting Chemokine 1, a Human CXC Chemokine Expressed in Lymphoid Tissues, Selectively Attracts B Lymphocytes via BLR1/CXCR5

TL;DR: The present results indicate that chemotactic recruitment by locally produced BCA-1 is important for the development of B cell areas of secondary lymphoid tissues.
Journal ArticleDOI

Recruitment of TNF Receptor 1 to Lipid Rafts Is Essential for TNFα-Mediated NF-κB Activation

TL;DR: It is suggested that lipid rafts are crucial for the outcome of TNFalpha-activated signaling pathways, which leads to the degradation via the proteasome pathway.
Journal ArticleDOI

CARMA1 is a critical lipid raft- associated regulator of TCR-induced NF-κB activation

TL;DR: The data show that CARMA1 is a critical lipid raft–associated regulator of TCR-induced NF-κB activation and CD28 costimulation–dependent Jnk activation and that it was constitutively associated with lipid rafts upon TCR engagement.